Juna M. de Vries

Neurologic syndromes related to anti-GAD65

Amaia Muñoz‐Lopetegi, Marienke A.A.M. de Bruijn, Sanae Boukhrissi et al. · Neurology Neuroimmunology & Neuroinflammation · 2020 · 183 citations · Full text

Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study

Nadine A. M. E. van der Beek, Juna M. de Vries, M.L.C. Hagemans et al. · Orphanet Journal of Rare Diseases · 2012 · 138 citations · Full text

Next-Day Effects of Ramelteon (8 mg), Zopiclone (7.5 mg), and Placebo on Highway Driving Performance, Memory Functioning, Psychomotor Performance, and Mood in Healthy Adult Subjects

Monique A. J. Mets, Juna M. de Vries, Lieke M. de Senerpont Domis et al. · SLEEP · 2011 · 130 citations · Full text

Long-term benefit of enzyme replacement therapy in Pompe disease

Esther Kuperus, Michelle E. Kruijshaar, Stephan C.A. Wens et al. · Neurology · 2017 · 122 citations

Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy

Deniz Güngör, Juna M. de Vries, Wim C.J. Hop et al. · Orphanet Journal of Rare Diseases · 2011 · 118 citations · Full text